A 28 for the top three hospitals in Beijing survey of doctors, continuing medical education programs are up to 63.4% in commercial sponsorship, and as many as 88.7% of doctors believe that commercial sponsorship is necessary.
Doctors participating in the survey that the pharmaceutical companies in the new knowledge of commercial sponsorship, digital thermometer promotion and application of new technology has played a positive role. However, the doctors admitted that the pursuit of the interests of pharmaceutical companies is the intention.
The survey designed by the Beijing Association for the implementation of medical education.clinical thermometer The survey covered hospitals directly under the Beijing Municipal Health Bureau, Ministry of Health subordinates Hospital, Peking University Hospital physician. Respondents, bachelor degree or above accounted for 93.5%, intermediate,digital blood pressure monitor and 86.8% above the title, there is deputy director of the administrative functions accounted for more than 83.5%. Participate in the annual national, ear thermometer provincial (municipal) level continuing education activities accounted for 96.1%.
Beijing Medical Education Association Vice President Jiaming Yan said that in the chronic shortage of funding for continuing medical education case, pharmaceutical companies increasingly enter the commercial sponsorship in the field of medical research and clinical treatment had a huge impact. How to effectively regulate and become a pressing problem.
Known by the industry is the cultivation of the medical health professionals need to go through three inter-linked, but not identical to the purpose and object composed of the stage - that college education, graduate medical education and continuing medical education.
The three stages of the continuum of medical education, has been universally recognized by the international medical community. Continuing Medical Education is the final stage of medical education and the highest level, health workers throughout the entire career.
Continuing Medical Education of the introduction of the concept of late. In 1988, the Ministry of Health was held in Hangzhou, the first continuing medical education seminars, was trying to give planning from a system perspective.
Money come from has always been plagued by continuing medical education. Ministry of Health in 1991 introduced the "Provisional Regulations on Continuing Medical Education" in the request, continuing medical education required to take various channels to raise funds to solve.
December 2000 Ministry of Health issued revised "continuing medical education requirements," said the funding for continuing medical education required to take the state, collectives and individuals in various channels to raise the solution. Health administrative departments at all levels of continuing medical education funding should be included in the budget. The health authorities should ensure a certain degree of continuing medical education costs, and raise funds through other channels.
Inadequate investment in other areas like health, continued medical education are often faced with the embarrassment of silver did not have accounts. At this point, the increasingly powerful pharmaceutical companies, especially multinationals, which saw the opportunity to enthusiastically join. Commercial sponsorship, the health system has become an indispensable element of continuing education.
"The introduction of commercial support for continuing medical education, medical personnel can be improved more medical and academic opportunities." Guangxi Education Department, Health Department Director Gengwen Kui said that in China, especially in primary health care institutions, medical personnel, medical knowledge of old, low level of medical technology, due to shortage of funds, little or no opportunity to participate in continuing medical education, make health care safety can not be guaranteed. Commercial support can effectively reduce the cost of continuing medical education, an increase of grassroots medical workers to participate in learning opportunities, to improve the diagnosis and treatment of grass-roots level of medical staff have great role in promoting. "To alleviate the financial pressure on the government and medical institutions, but also have a positive effect."
Beijing Medical Education Association survey, the respondents agreed that doctors: pharmaceutical companies are more willing to sponsor continuing medical education of high-level activities, including national, provincial (ministry) level continuing education programs, especially high level, the social impact force, highly academic, more large-scale academic conference participants; support of medical personnel to attend CME (follow-up medical education) sessions, accounting for 51.8%. Pharmaceutical companies are particularly willing to sponsor and medical equipment and medicines related professional activities, cardiovascular, God, the kidney, surgery of the professional (bone, outside of God), tumor, imaging, intervention, clinical trials of drugs and other professional more preferences.
"A lot of medical staff reflects the number of pharmaceutical companies over issues of academic activities organized limitations, they talk about topics related with the product, but also beneficial to talk about their products or about the views and evidence in individual cases, the findings The tendency to explain the obvious. "Beijing Friendship Hospital, Capital Medical University, Liver Research Center, Ji-Dong Jia said the company, after all, is to have commercial interests, and its academic sponsor will not tell exactly the same motivation.
Beijing Medical Education Association, the survey said business sponsorship of continuing medical education to give a lot of money and material support, the doctors do not think it accounted for 66.8% of voluntary unpaid. "Commercial sponsorship inevitably driven by interests, with their business objectives. Are indeed a small number of commercial sponsorship by pharmaceutical companies trying to influence the choice of physicians for treatment and medication behavior, drug safety hazards, and even deep-seated commercial bribery . "Jiaming Yan said.
"The correct approach is, we can not allow manufacturers to dominate or interfere with the academic sponsor the content, so that business interests beyond the academic independence and academic just the bottom line should not be sponsored by the pharmaceutical companies as a scourge." Ji-Dong Jia said that the subject of academic exchanges in the choice of invited speakers and identify the specific academic content, arrangement, etc., should be fully independent academic committee of experts to decide the venue should not have any products, but also learn from practice in developed countries like Europe and America, asked an academic report must Declaration I, and pharmaceutical companies for any economic and business contacts.
Jiaming Yan said the government departments need to sponsor continuing medical education in the introduction of policies and regulations and management system, standardize the scope of sponsorship.